Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Genitourinary 3Gynecologic 2CNS 2Thoracic 1Sarcoma 1Head & Neck 1Dermatologic 1

Conditions

Vulvar Neoplasms 1Ovarian Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Circulating Tumor DNA × Gynecologic × Clear all
NCT04846933 2025-01-16

DECIDER

Turku University Hospital

Phase NA Recruiting
200 enrolled
Gynecologic

Ovarian Neoplasms

NCT06582108 2024-09-03

ROAR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting
190 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡